Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Alternative splicing of (ppp1r12a/mypt1) in zebrafish produces a novel myosin phosphatase targeting subunit.

LaFlamme A, Young KE, Lang I, Weiser DC.

Gene. 2018 Oct 30;675:15-26. doi: 10.1016/j.gene.2018.06.092. Epub 2018 Jun 28.

PMID:
29960069
2.

Characterization of the three zebrafish orthologs of the mitochondrial GTPase Miro/Rhot.

Hollister BM, Oonk KA, Weiser DC, Walsh S.

Comp Biochem Physiol B Biochem Mol Biol. 2016 Jan;191:126-34. doi: 10.1016/j.cbpb.2015.10.006. Epub 2015 Oct 19.

PMID:
26482085
3.

Characterization of the zebrafish homolog of zipper interacting protein kinase.

Carr BW, Basepayne TL, Chen L, Jayashankar V, Weiser DC.

Int J Mol Sci. 2014 Jun 30;15(7):11597-613. doi: 10.3390/ijms150711597.

4.

Protein phosphatase 1 β paralogs encode the zebrafish myosin phosphatase catalytic subunit.

Jayashankar V, Nguyen MJ, Carr BW, Zheng DC, Rosales JB, Rosales JB, Weiser DC.

PLoS One. 2013 Sep 11;8(9):e75766. doi: 10.1371/journal.pone.0075766. eCollection 2013.

5.

Analysis of cell shape and polarity during zebrafish gastrulation.

Weiser DC, Kimelman D.

Methods Mol Biol. 2012;839:53-68. doi: 10.1007/978-1-61779-510-7_5.

6.

Alternative splicing of sept9a and sept9b in zebrafish produces multiple mRNA transcripts expressed throughout development.

Landsverk ML, Weiser DC, Hannibal MC, Kimelman D.

PLoS One. 2010 May 19;5(5):e10712. doi: 10.1371/journal.pone.0010712.

7.

Rho-regulated myosin phosphatase establishes the level of protrusive activity required for cell movements during zebrafish gastrulation.

Weiser DC, Row RH, Kimelman D.

Development. 2009 Jul;136(14):2375-84. doi: 10.1242/dev.034892. Epub 2009 Jun 10.

8.

Cell shape regulation by Gravin requires N-terminal membrane effector domains.

Weiser DC, St Julien KR, Lang JS, Kimelman D.

Biochem Biophys Res Commun. 2008 Oct 31;375(4):512-516. doi: 10.1016/j.bbrc.2008.08.063. Epub 2008 Aug 24.

9.

Use of protein phosphatase inhibitors.

Weiser DC, Shenolikar S.

Curr Protoc Protein Sci. 2003 May;Chapter 13:Unit 13.10. doi: 10.1002/0471140864.ps1310s31.

PMID:
18429239
10.

Use of protein phosphatase inhibitors.

Weiser DC, Shenolikar S.

Curr Protoc Mol Biol. 2003 May;Chapter 18:Unit 18.10. doi: 10.1002/0471142727.mb1810s62.

PMID:
18265323
11.
12.

Importance of a surface hydrophobic pocket on protein phosphatase-1 catalytic subunit in recognizing cellular regulators.

Gibbons JA, Weiser DC, Shenolikar S.

J Biol Chem. 2005 Apr 22;280(16):15903-11. Epub 2005 Feb 9.

13.

The inhibitor-1 C terminus facilitates hormonal regulation of cellular protein phosphatase-1: functional implications for inhibitor-1 isoforms.

Weiser DC, Sikes S, Li S, Shenolikar S.

J Biol Chem. 2004 Nov 19;279(47):48904-14. Epub 2004 Sep 2.

14.

PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Margolis SS, Walsh S, Weiser DC, Yoshida M, Shenolikar S, Kornbluth S.

EMBO J. 2003 Nov 3;22(21):5734-45.

16.

Neurabins recruit protein phosphatase-1 and inhibitor-2 to the actin cytoskeleton.

Terry-Lorenzo RT, Elliot E, Weiser DC, Prickett TD, Brautigan DL, Shenolikar S.

J Biol Chem. 2002 Nov 29;277(48):46535-43. Epub 2002 Sep 21.

17.
18.

Eosinophilic enteritis associated with chronic eosinophilic pneumonia.

Marnocha KE, Maglinte DD, Kelvin FM, McCune M, Weiser DC, Strate R.

Am J Gastroenterol. 1986 Dec;81(12):1205-8.

PMID:
3788932
19.

Cefazolin in the treatment of acute lower respiratory tract infections.

Weiser DC, Winter LW, Farber MO, Bright TP, Shinwarie NM, Smith JW.

Curr Ther Res Clin Exp. 1976 Jan;19(1):1-10. No abstract available.

PMID:
812653

Supplemental Content

Loading ...
Support Center